Information from the Hong Kong Stock Exchange reveals that on June 16, Executive Director Tang Minjie acquired 5,000 shares of Haohai Biotec (HKEX: 06826) at a price of HK$16.12 per share, involving a total sum of approximately HK$80,600.
Following this transaction, his latest shareholding stands at around 50,400 shares, representing a stake of 0.14% in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.